ganagliflozin

DRUG2 trials

Sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Conditions

CKD - Chronic Kidney DiseaseT2DM (Type 2 Diabetes Mellitus)

Phase 4

Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Not yet recruitingNCT07116928

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.CKD - Chronic Kidney Disease, T2DM (Type 2 Diabetes Mellitus)

Start: 2025-11-30End: 2031-12-30Target: 1244Updated: 2025-11-18

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

RecruitingNCT07244003

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.T2DM (Type 2 Diabetes Mellitus)

Start: 2025-03-29End: 2028-06-30Target: 430Updated: 2025-11-24